Accretion Nutraveda Ltd

BSE: 544694 · Pharmaceuticals & Biotechnology · 2 announcements

Share price: ₹271.75
Market cap: ₹196.8 Cr
Revenue (annual): ₹33.60 Cr
Net profit (annual): ₹5.07 Cr
P/E (TTM): 38.8×Sector 50.4×
Promoter holding: 73.48%+0.00% QoQ
FII holding: 1.08%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

9 Sep 2026 21:19 IST BSE

Annual General Meeting

Accretion Nutraveda Annual General Meeting

Accretion Nutraveda Limited issued a Notice of Postal Ballot to seek shareholder approval for the alteration of its Memorandum of Association. Voting concludes on October 9, 2026.

Read the filing ↗

8 May 2026 18:53 IST BSE

Financial Results

Accretion Nutraveda H2 FY26 Results: Net Profit ₹2.7 Cr, Up 58.8% YoY

Accretion Nutraveda Ltd reported revenue from operations of ₹19.5 Cr (+80.6% YoY) and net profit of ₹2.7 Cr (+58.8% YoY) for H2 FY26.

Key figure: Net profit ₹2.7 Cr · +58.8% YoY

Open full results → Read the filing ↗